The Global Triptorelin Market Size Was Valued at USD 10.50 Billion in 2023 and is Projected to Reach USD 16.42 Billion by 2032, Growing at a CAGR of 5.10% From 2024-2032. Triptorelin is a potent synthetic agonist analog of gonadotropin-releasing hormone (GnRH) used extensively in the management of hormone-responsive cancers and various reproductive health conditions. By providing continuous...